Efficacy and Safety of 590 Nm and 590/630 Nm Light‐Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial
Photodermatology, Photoimmunology & Photomedicine · 2026-05 · 42 (3)
DOI: 10.1111/phpp.70090 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 07.04.2026. Verfasst von Xuanxuan He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Phototherapy. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Outstanding project of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Objectives
Sensitive skin (SS) is a prevalent condition characterized by exaggerated sensory responses to environmental stimuli. Emerging evidence suggests that light‐emitting diode (LED) therapy may alleviate SS symptoms by modulating inflammation and enhancing skin barrier function. This study aimed to evaluate the efficacy and safety of 590 nm yellow LED monotherapy versus the combination of 590 nm and 630 nm red‐yellow LED therapy in SS patients.
Methods
A single‐center, prospective, randomized controlled trial was conducted on 30 volunteers diagnosed with SS. Participants were randomized into three groups: Group A (control, emollient only), Group B (590 nm yellow light, 10 mW/cm 2 , 11 min, thrice weekly), and Group C (590/630 nm dual light, 30 mW/cm 2 , 10 min, thrice weekly). Outcomes were assessed using the Laurent Misery sensitive scale‐10 (SS‐10) questionnaire, Thinkview imaging, transepidermal water loss (TEWL), pH value, erythema index (EI), melanin index (MI), and lactic acid sting test (LAST). Participants were evaluated at baseline and at follow‐up visits during Weeks 2, 4, and 8.
Results
Both LED treatment groups showed significant improvements in SS‐10 scores compared to the control ( p = 0.0025 and p < 0.0001). The 590 nm LED yellow light treatment markedly reduced EI ( p = 0.0282), MI ( p = 0.0109), TEWL ( p = 0.0479) and showed superior improvements in LAST ( p = 0.0013) compared with control, while 590/630 nm LED irradiation reduced lactic acid sting scores significantly compared with control ( p = 0.0239). No adverse events were reported.
Conclusions
LED light therapy, particularly 590 nm yellow light, is a safe and effective modality for alleviating SS symptoms, with dual‐wavelength therapy showing complementary benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Xuanxuan He, Muyang He, Chengfeng Zhang, Shanglin Jin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
- Outstanding project of Shanghai Municipal Health Commission
- National Key Research and Development Program of China
- Clinical Research Special Program of Shanghai Municipal Health Commission
Zitieren
APA
He, X., He, M., Wang, X., Zhang, C., & Jin, S. (2026). Efficacy and Safety of 590 Nm and 590/630 Nm Light‐Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial. Photodermatology, Photoimmunology & Photomedicine, 42(3). https://doi.org/10.1111/phpp.70090
Vancouver
He X, He M, Wang X, Zhang C, Jin S. Efficacy and Safety of 590 Nm and 590/630 Nm Light‐Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial. Photodermatology, Photoimmunology & Photomedicine. 2026;42(3). doi:10.1111/phpp.70090
BibTeX
@article{He2026,
author = {He, Xuanxuan and He, Muyang and Wang, Xuchao and Zhang, Chengfeng and Jin, Shanglin},
title = {Efficacy and Safety of 590 Nm and 590/630 Nm Light‐Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2026},
volume = {42},
number = {3},
doi = {10.1111/phpp.70090}
}
EUVIMED